Oncovin and blood alkaline phosphatase increased Patient Reports February 09, 2010

Oncovin Side Effects Report #4662759-8
Oncovin side effect was reported by a Physician from on Apr 26, 2005. Female patient, 71 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, laboratory test abnormal, liver disorder, neutrophil count decreased. Oncovin dosage: 1.4 MG OTHER. During the same period patient was treated with CYCLOPHOSPHAMIDE, DAUNORUBICIN HYDROCHLORIDE, LEUNASE, FAMOTIDINE, FIRSTCIN, ISEPACIN, KYTRIL. Patient recovered.

Oncovin Side Effects Report #4620255-8
Oncovin side effect was reported by a Physician from on Mar 09, 2005. Female patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase decreased, blood fibrinogen decreased, gamma-glutamyltransferase increased, hepatic function abnormal. Oncovin dosage: 1.3 MG/M2 OTHER. During the same period patient was treated with DAUNORUBICIN, CYCLOPHOSPHAMIDE, ELSPAR, PREDNISOLONE. Patient recovered.

Oncovin Side Effects Report #4649843-X
Oncovin side effect was reported by a Physician from on Apr 08, 2005. Female patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase decreased, blood fibrinogen decreased, condition aggravated. Oncovin dosage: 1.3 MG/M2 OTHER. During the same period patient was treated with DAUNORUBICIN, CYCLOPHOSPHAMIDE, LEUNASE, PREDNISOLONE. Patient recovered.